Alpha Lipoic Acid Capsule (ALA), also known as Thioctic Acid, is an antioxidant product that addresses diabetic neuropathy. The company will be one of the two pharmaceutical companies
The national chain will be carrying two BluScience SKUs (HeartBlu and EternalBlu) by the end of first quarter of 2012. Two additional SKUs (MemoryBlu and Blu2Go) will also
As per the agreement, the US rights to the Resolor trademark will be transferred to Shire. Resolor is approved for use in 33 countries for the symptomatic treatment
GDNF is a naturally-occurring growth factor capable of protecting and promoting the survival of dopamine producing nerve cells. MedGenesis chairman and CEO Erich Mohr said they hope that
The FDA considers the resubmission a complete, class 2 response and assigned a new Prescription Drug User Fee Act (PDUFA) target date of 27 June 2012, the company
MidaSol non-injectable Insulin addresses the unmet need of diabetic patients who are dependent on insulin injections by providing a more convenient, non invasive, treatment option. The companies are
As per the agreement Servier will engage BioInvent to screen its proprietary n-CoDeR library for antibodies specific to the undisclosed target. Servier will also have access to BioInvent’s
The 390-patient study will compare the safety and effectiveness of HA-Irinotecan with irinotecan in a double blind trial in second and third line metastatic colorectal cancer patients (mCRC).
The biopharmaceuticals are produced utilizing Ossianix’s Osss proprietary single domain antibody platform modeled on the shark vNAR structure. Lundbeck will retain the right to negotiate for certain products
Remodulin is approved for the continuous subcutaneous infusion treatment of idiopathic or heritable PAH to improve exercise tolerance and symptoms of the disease. For intravenous Remodulin, United Therapeutics
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.